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Introduction / objectives
Over the years, there has been an increase in infection
rates associated with vancomycin-resistant Enterococcus
(VRE). Patients with VRE with clinical findings may
show signs and symptoms of infection of the urinary
tract, bloodstream, wounds, abdominal pain, diarrhea
and can progress to septic shock. However, patients may
be colonized and have no signs and symptoms, but they
represent a strong threat in the spread of bacteria. In
the body of the colonized subject, the most important
reservoir of VRE is the gastrointestinal tract, especially
the colon.
Methods
This is an experience report retrospective from 2005 to
2010, involving the description of the monitoring of 547
cases of patients who fit the protocols for surveillance of
a General Hospital of São Paulo. The 437 cases evalu-
ated by collecting a sample of anal swab for VRE in the
research situation Empirical Contact Precautions (at
admission) and 110 cases evaluated in Directed Surveil-
lance, including a collection of four samples from each
patient, considering the criterion of patient risk.
Results
In the sample of 437 patients investigated, 2.28% of
patients had positive VRE while in the performance of
periodic surveillance directed at patients at risk (110
cases), 8.08% showed positive result for the VRE.
Conclusion
This report demonstrates the prevalence of VRE, consid-
ering the microorganisms found in patients who are
admitted in Empirical Contact Precautions and the
importance of directed surveillance to microorganisms
such as VRE, Clostridium difficile and KPC production.
Evidence of colonization of patients means it can be
empirical precaution and thus provide patient safety by
minimizing the risk of nosocomial infection.
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